Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury
NCT07625553Phase 2Recruiting
- Sponsor
- River 2 Renal Corp
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of R2R01 in acute kidney injury (AKI) (3 arms), sponsored by River 2 Renal Corp. Primary endpoint: Proportion of subjects developing Acute Kidney Injury at 18 months. Started Apr 2026; status: recruiting.
02
Drugs
R2R01
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07625553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07625553.